Hikma Pharmaceutical | HIK - Net Income


Hikma Pharmaceutical reported $164M in Net Income for its fiscal semester ending in December of 2025.





Net Income Change Date
Almirall EUR 19.58M 7M Dec/2025
argenx SE USD 472M 106M Jun/2026
AstraZeneca USD 2.51B 573M Jun/2026
Autolus Therapeutics Ltd USD -71.6M 18.73M Mar/2026
Bayer EUR 2.76B 6.52B Mar/2026
Fresenius EUR 382M 53M Jun/2026
Genmab DKK 31M 370M Dec/2025
GlaxoSmithKline GBP 435M 1.3B Jun/2026
GRIFOLS EUR 154M 81M Jun/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Lakefront Biotherapeutics EUR 14.49M 767.65M Mar/2026
Lonza CHF 426M 119M Jun/2025
Merck EUR 659M 340M Mar/2026
Orion EUR 140.2M 49.8M Jun/2026
Recordati EUR 116.61M 36.45M Jun/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Sanofi EUR 343M 1.27B Jun/2026
UCB EUR 1.08B 608M Dec/2025